PharmaCyte Biotech, Inc. - Significant Ownership

Signature - Title
/s/ Carlos Trujillo - Carlos Trujillo
Location
Laguna Hills, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by PharmaCyte Biotech, Inc..

Significant Ownership of PharmaCyte Biotech, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QCLS Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share 74% $28.6M 8.48M PharmaCyte Biotech, Inc. Nov 14, 2025

Schedules 13D/G Reported by PharmaCyte Biotech, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.